Breast Cancer Study of Preoperative Pembrolizumab + Radiation

NCT03366844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: RT Boost

Sponsor

Stephen Shiao

Collaborators

[object Object]